IRIS
MONTORSI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 36.376
NA - Nord America 19.669
EU - Europa 16.091
SA - Sud America 11.784
AF - Africa 868
OC - Oceania 114
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 1
Totale 84.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.685
SG - Singapore 15.493
BR - Brasile 9.895
CN - Cina 8.782
HK - Hong Kong 5.699
SE - Svezia 4.496
IT - Italia 3.712
VN - Vietnam 3.152
RU - Federazione Russa 2.416
DE - Germania 1.147
RO - Romania 817
AR - Argentina 783
FI - Finlandia 717
IN - India 673
GB - Regno Unito 566
ID - Indonesia 501
CA - Canada 411
NL - Olanda 386
MX - Messico 352
EC - Ecuador 349
IE - Irlanda 337
BD - Bangladesh 317
JP - Giappone 288
ZA - Sudafrica 263
IQ - Iraq 260
FR - Francia 241
TR - Turchia 237
ES - Italia 224
PL - Polonia 219
AT - Austria 216
CO - Colombia 208
PY - Paraguay 155
UA - Ucraina 149
PK - Pakistan 125
MA - Marocco 118
EG - Egitto 109
CL - Cile 107
VE - Venezuela 104
UZ - Uzbekistan 98
AU - Australia 89
PE - Perù 79
IR - Iran 75
SA - Arabia Saudita 74
UY - Uruguay 67
LT - Lituania 65
KE - Kenya 63
AE - Emirati Arabi Uniti 62
TN - Tunisia 62
NG - Nigeria 59
DZ - Algeria 52
NP - Nepal 52
DO - Repubblica Dominicana 50
JO - Giordania 49
AZ - Azerbaigian 48
CH - Svizzera 48
BE - Belgio 41
IL - Israele 39
MY - Malesia 39
KZ - Kazakistan 37
KR - Corea 34
TW - Taiwan 33
CZ - Repubblica Ceca 29
GR - Grecia 29
BG - Bulgaria 27
JM - Giamaica 27
BO - Bolivia 25
AL - Albania 24
HN - Honduras 24
NO - Norvegia 21
RS - Serbia 21
BH - Bahrain 20
OM - Oman 20
PH - Filippine 20
TH - Thailandia 20
KW - Kuwait 19
LB - Libano 19
PA - Panama 18
PT - Portogallo 18
BA - Bosnia-Erzegovina 17
CR - Costa Rica 17
SN - Senegal 17
TT - Trinidad e Tobago 17
GT - Guatemala 16
TZ - Tanzania 16
BY - Bielorussia 15
DK - Danimarca 15
PS - Palestinian Territory 15
SV - El Salvador 15
BB - Barbados 14
XK - ???statistics.table.value.countryCode.XK??? 14
HU - Ungheria 13
NZ - Nuova Zelanda 13
SC - Seychelles 13
HR - Croazia 12
ET - Etiopia 11
AO - Angola 10
KG - Kirghizistan 10
MK - Macedonia 10
AM - Armenia 9
CI - Costa d'Avorio 9
Totale 84.703
Salva come PNG Salva come JPEG
Città #
Singapore 6.023
Hong Kong 5.664
Dallas 4.974
Hefei 2.271
Shanghai 2.233
Lawrence 2.119
Princeton 2.113
Ashburn 2.003
Ho Chi Minh City 1.209
Moscow 1.081
Milan 833
New York 778
São Paulo 772
Beijing 748
Hanoi 651
Helsinki 534
Los Angeles 489
Rio de Janeiro 338
Dublin 332
Munich 291
Boardman 278
Rome 261
Belo Horizonte 210
Nuremberg 203
Brasília 189
Tokyo 170
Warsaw 169
Brooklyn 162
Pune 162
Curitiba 153
Montreal 152
Santa Clara 143
Porto Alegre 135
Denver 132
Guangzhou 132
Johannesburg 132
Turku 132
Haiphong 129
Campinas 123
Chennai 118
Da Nang 116
The Dalles 114
Atlanta 113
Guayaquil 112
Orem 112
Quito 110
Stockholm 106
Vienna 104
Seattle 103
Biên Hòa 102
Turin 101
Columbus 100
Guarulhos 99
Salvador 96
London 95
Poplar 94
Chicago 92
Washington 91
Thái Bình 90
Boston 88
Jakarta 86
Phoenix 86
Toronto 85
Ribeirão Preto 84
Tashkent 83
Houston 81
Tianjin 81
Baghdad 79
Naples 78
Frankfurt am Main 76
Hangzhou 76
Hải Dương 76
Mexico City 76
Goiânia 72
Manaus 72
Manchester 72
Recife 72
Fortaleza 71
Bologna 70
Caxias do Sul 66
Dhaka 66
Amsterdam 64
Ankara 64
Mumbai 64
Buenos Aires 63
Sumaré 61
Santo André 60
Council Bluffs 59
Florence 59
Valencia 59
Istanbul 58
Osasco 58
Ninh Bình 56
San Francisco 54
Montevideo 53
Sorocaba 52
Cape Town 51
Erbil 51
Paris 50
Asunción 49
Totale 43.472
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.629
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.361
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis 461
Benign Prostatic Hyperplasia and Its Aetiologies 424
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers 373
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 342
High serum alpha-fetoprotein levels in primary infertile men 329
Women's sexual dysfunction: a pathophysiological review 277
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 179
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 174
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 162
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 148
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 137
Organic vs. Psychogenic? The Manichean Diagnosis in Sexual Medicine 134
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 131
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 126
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 122
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 112
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 112
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 109
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 108
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 107
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 107
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 106
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 105
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 104
Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study 103
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 103
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 103
Nasal congestion after visual sexual stimulation with and without sildenafil (Viagra (R)): a randomized placebo-controlled study 102
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 102
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 102
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 101
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 101
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 100
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 100
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 100
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 100
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 99
Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. 96
4-DRUG INTRACAVERNOUS THERAPY FOR IMPOTENCE DUE TO CORPOREAL VENOOCCLUSIVE DYSFUNCTION 96
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 95
[In Process Citation]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 94
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 93
[Management of erectile dysfunction in patients with preexisting cardiovascular disease]. FT Disfunzione erettile nel paziente cardiopatico: diagnosi e raccomandazioni terapeutiche. 92
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 92
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 92
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 91
Hyperestrogenism is associated with sexual function impairment in men-findings from a cross-sectional, real-life study 89
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 89
[Not Available]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 89
Prediction of Sexual Function After Radical Prostatectomy 89
Pelvic lymph node dissection in prostate cancer 89
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 89
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 89
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 89
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 88
The Importance of Discordant Follicle Stimulating Hormone and Inhibin B Levels in Primary Infertile Men: Findings from a Cross-Sectional Study 88
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 87
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 87
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 86
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 86
[Management and prevention of catheter-associated urinary tract infections: current opinions and clinical practice]. FT Gestione e prevenzionedelle infezioni delle vieurinarie associate a catetere:opinioni e pratica clinica. 86
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 86
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 86
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 85
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 84
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 84
A global approach to improving penile cancer care 84
Long-term safety and tolerability of thdalafil in the treatment of erectile dysfunction 84
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 84
Medications mostly associated with priapism events: assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries 83
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 83
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 82
Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses 82
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 80
Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study 80
Correlation among isolated teratozoospermia, sperm DNA fragmentation and markers of systemic inflammation in primary infertile men 80
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 79
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 79
Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center 79
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 79
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 78
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 78
PROSTATIC UROLUME WALLSTENT FOR BENIGN PROSTATIC HYPERPLASIA PATIENTS AT POOR OPERATIVE RISK - CLINICAL, UROFLOWMETRIC AND ULTRASONOGRAPHIC PATTERNS 78
How to Select the Optimal Candidates for Renal Mass Biopsy 78
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 77
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 77
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 76
Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate in Patients Under Either Anticoagulation or Antiplatelet Therapy 76
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 75
A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies 75
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 75
Haemospermia in the Real- Life Setting: A New High-Risk Stratification 75
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 74
[Not Available]. FT Second-look precoce par ureteroscopie souple apres traitement endoscopique conservatif pour tumeur de la voie excretrice urinaire superieure: resultats preliminaires. 74
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 74
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 74
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve 73
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 73
Totale 13.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 762.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 762.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 124 8 2 11 6 8 2
2021/20221.273 1 58 30 577 61 65 90 75 42 69 55 150
2022/202310.126 4.873 1.738 601 119 68 1.013 434 606 272 96 151 155
2023/20245.160 235 279 399 356 413 922 292 508 90 383 562 721
2024/202529.158 4.249 726 542 672 691 2.350 4.169 2.213 5.247 4.330 1.813 2.156
2025/202639.645 5.690 7.391 7.341 12.527 5.552 1.144 0 0 0 0 0 0
Totale 86.119